Vasopressin and V2 Receptor in Meniere's Disease

计划入组 135 人 · 首次发布于 2008 年 1 月 23 日

Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).

计划入组 338 人 · 首次发布于 2002 年 4 月 1 日

DILIPO (DILutIonal HyPOnatremia)

计划入组 150 人 · 首次发布于 2006 年 1 月 10 日

Tolvaptan(Jinarc, Jynarque 45/15 Carton, Samsca, Tolvaptan Accord)

C₂₆H₂₅ClN₂O₃

Vasopressin(Vasostrict)

C₉₂H₁₃₀N₂₈O₂₄S₄ · Rx

Vasopressin Tannate

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

Tolvaptan Shows Promise as Universal Pharmacological Chaperone for Rare Disease Treatment

Mezzion Reports Positive In Vivo Results for PDE5 Inhibitor Udenafil in ADPKD, Plans Phase 2b Trial

Vasopressin Shows Promise as Alternative to Epinephrine in Neonatal Resuscitation Study